Washington The first Amerian could be vaccinated against coronavirus on December 11. According to the CNN news server, this was stated on Sunday by Moncef Slaoui, who will be a specialist in the overall operation.
The pharmaceutical company Pfizer asked the US Food and Drug Administration (FDA) enough about the extraordinary deployment of its covid-19 vaccine. The FDA Advisory Committee on Vaccines is due to meet on December 10.
The pharmaceutical company Pfizer was the first company in the USA to use its vaccine extraordinarily |
He said that if the vaccine was approved, it could be distributed the next day. It is fully possible that we will be able to send vaccines to the city for immunization within 24 hours of approval, said Slaoui, a former vaccine developer in the GlaxoSmithKline pharmaceutical giant.
The forging project will be called Operation Warp Speed, according to a fictitious method of traveling super-light speed from the sci-fi series Star Trek. The CNN server reminds us that the most vulnerable groups, such as health workers, the elderly and people with other health problems, should be vaccinated first.
Pfizer, which is cooperating with the German BioNTech on vaccination, recently informed the public about the completion of the last phase of clinical trials. She has shown that the vaccine is about 95 percent in all age groups and has no side effects. Pfizer said that this year it would like to produce about 50 million doors, which will cost 25 million people.
The Pfizer vaccine will be available this year, the company said. It confirmed the activity of 95 percent |
He gave the company, which, according to the extraordinary approval of its prepartum, will be the company Moderna. Preliminary results of the final tests of its preparticle showed comparable activity as with the Pfizer vaccine.
Plates of companies all over the world are working on the development of vaccine vaccines. As AstraZeneca in particular gave the results of its tests, it cooperates with Oxford University. This year, Jet & Johnson wants to inform Johnson & Johnson about their progress.
–
–
– .
